These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 207512)

  • 21. Cross-activation: overriding cAMP/cGMP selectivities of protein kinases in tissues.
    Jiang H; Shabb JB; Corbin JD
    Biochem Cell Biol; 1992 Dec; 70(12):1283-9. PubMed ID: 1338568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of cAMP-dependent protein kinase subunits.
    Geahlen RL; Carmichael DF; Hashimoto E; Krebs EG
    Adv Enzyme Regul; 1982; 20():195-209. PubMed ID: 6287816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cyclic adenosine 3', 5' -mono-phosphate dependent protein kinase of rat ovarian cells by luteinizing hormone and human chorionic gonadotropin.
    Azhar S; Clark MR; Menon KM
    Endocr Res Commun; 1976; 3(2):93-104. PubMed ID: 182451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action.
    Francis SH; Corbin JD
    Crit Rev Clin Lab Sci; 1999 Aug; 36(4):275-328. PubMed ID: 10486703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of follicle stimulating hormone and luteinizing hormone upon cyclic AMP and cyclic GMP levels in rat ovaries in vitro.
    Ratner A
    Endocrinology; 1976 Dec; 99(6):1496-500. PubMed ID: 187411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New evidence for compartmentalization of ovarian 3',5'-cyclic AMP-dependent protein kinase activity.
    Albertson BD; Vaitukaitis JL
    Endocrinology; 1977 Nov; 101(5):1413-20. PubMed ID: 199418
    [No Abstract]   [Full Text] [Related]  

  • 27. Rabbit ovarian protein kinases. II. Effect of an ovulatory dose of human chorionic gonadotropin or luteinizing hormone on the multiplicity of follicular and luteal protein kinases.
    Hunzicker-Dunn M; Jungmann RA
    Endocrinology; 1978 Aug; 103(2):431-40. PubMed ID: 570495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutating protein kinase cAMP-binding sites into cGMP-binding sites. Mechanism of cGMP selectivity.
    Shabb JB; Buzzeo BD; Ng L; Corbin JD
    J Biol Chem; 1991 Dec; 266(36):24320-6. PubMed ID: 1662209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cGMP-dependent protein kinase mediates the reduction of Ca2+ by cAMP in vascular smooth muscle cells.
    Lincoln TM; Cornwell TL; Taylor AE
    Am J Physiol; 1990 Mar; 258(3 Pt 1):C399-407. PubMed ID: 2156436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic nucleotides and prostaglandins (PGs) produced by the rabbit oviduct: effects of estrogen treatment.
    Valenzuela G; Antonini R; Hodgson BJ; Jones DJ; Harper MJ
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):361-4. PubMed ID: 195319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished response of ovarian cAMP to luteinizing hormone in experimental uremia.
    Kreusser W; Mader H; Haag WD; Ritz E
    Kidney Int; 1982 Sep; 22(3):272-9. PubMed ID: 6294398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of 3':5'-cyclic GMP-dependent protein kinase.
    Gill GN; Holdy KE; Walton GM; Kanstein CB
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):3918-22. PubMed ID: 186778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis between cyclic GMP and cyclic AMP signalling in human sperm.
    Willipinski-Stapelfeldt B; Lübberstedt J; Stelter S; Vogt K; Mukhopadhyay AK; Müller D
    Mol Hum Reprod; 2004 Jul; 10(7):543-52. PubMed ID: 15121877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein phosphotransferase activities and cyclic nucleotide action in proliferating lymphocytes.
    Masaracchia RA; Walsh DA
    Cancer Res; 1976 Sep; 36(9 pt.1):3227-37. PubMed ID: 184945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced follicle-stimulating hormone activity of deglycosylated human chorionic gonadotropin in ovarian granulosa cells.
    Ranta T; Chen HC; Shimohigashi Y; Baukal AJ; Knecht M; Catt KJ
    Endocrinology; 1985 Jan; 116(1):59-64. PubMed ID: 2981077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple inhibitory actions of luteinizing hormone-releasing hormone agonist on luteinizing hormone/human chorionic gonadotropin receptor-mediated ovarian responses.
    Reddy PV; Azhar S; Menon KM
    Endocrinology; 1980 Oct; 107(4):930-6. PubMed ID: 6250799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermediate role of adenosine 3':5'-cyclic monophosphate and protein kinase during gonadotropin-induced steroidogenesis in testicular interstitial cells.
    Dufau ML; Tsuruhara T; Horner KA; Podesta E; Catt KJ
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3419-23. PubMed ID: 198785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of human chorionic gonadotropin and response of cyclic nucleotides to luteinizing hormone in luteal tissue from rats treated with prostaglandin F2alpha.
    Grinwich DL; Ham EA; Hichens M; Behrman HR
    Endocrinology; 1976 Jan; 98(1):146-50. PubMed ID: 174888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of human chorionic gonadotrophin on the release of cyclic AMP and progesterone from the sheep ovary at different stages of the oestrous cycle.
    Weiss TJ; Janson PO; Porter KJ; Seamark RF
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):158-65. PubMed ID: 211774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.